At Typeone, we empower
the future of regenerative medicine
by mastering collagen science.

At Typeone, we empower
the future of regenerative medicine by mastering collagen science.

We are dedicated to developing and manufacturing advanced biomaterials from raw collagen to certified medical devices serving as both a trusted CDMO partner and a provider of innovative, clinically proven products.

Through deep scientific expertise, regulatory excellence, and a commitment to high-quality manufacturing, we support our partners worldwide in transforming biomaterial innovation into therapeutic solutions for dermatology, orthopedics, wound care, and beyond.

Our mission is to bridge the gap between cutting-edge research and real-world medical applications delivering safe, effective, and transformative collagen-based technologies that improve lives globally.

Deep with collagen,

The Story of Typeone:

A Journey of Innovation in Collagen Science
2019
2020
2021
2022
2023
2024

Foundation of TypeOne Biomaterials as a technological startup, with the goal of revolutionizing regenerative medicine through advanced collagen-based materials.

Year dedicated to validating production processes and certifying the first products, establishing solid scientific foundations for future expansion.

Obtaining CE marking, completion of biocompatibility, stability, and sterilization tests, consolidating regulatory compliance.​

Merger with SIRYO corporation, ISO13485 certification, and inauguration of a new production facility, significantly expanding operational capabilities.​

Enhancement of marketing efforts and increase in production scale, allowing the company to reach new markets with innovative biomedical solutions.​

Development of new formulations, pioneering applications, and strategic partnerships that expand the company’s scientific horizon.​

From innovative startup to leader in the biomedical sector, TypeOne has charted a path of constant growth, driven by scientific excellence and commitment to innovation. Today, our mission is to empower the future of regenerative medicine through mastery of collagen science.

We dedicate ourselves to the development and production of advanced biomaterials from raw collagen to certified medical devices serving both as a reliable CDMO partner and as a provider of innovative and clinically proven products. 

Thanks to our deep scientific expertise, regulatory excellence, and forward-thinking vision, we continue to redefine the boundaries of regenerative medicine to improve the lives of patients worldwide.

building designed with precision
A 0
dedicated to production
The area includes 0
for administrative offices
0

Main equipment and facilities

TypeOne ISO8 Clean Room​

ISO8 Clean Room​

Ultra-controlled 90m² environment with advanced air filtration systems. Ensures optimal conditions for sterile production.

Typeone Purified Water Production System​

Purified Water
Production System​

500L/h capacity with reverse osmosis technology. Provides highest quality water for production processes.

Typeone Rotary Atomizer​

Rotary Atomizer​

5.0L/h productivity with micrometric precision. Transforms liquid solutions into finest powders through high-speed rotation.

Typeone Powder Filling Machine​

Powder Filling Machine​

180 pieces/hour capacity with high-precision dosing. Automates the packaging process with integrated quality control.

System certifications​

Our certifications guarantee controlled processes
and reliable products.

Every phase of production follows rigorous quality protocols verified by independent certification bodies.

  • Typeone

Certified Excellence​
International standards recognized worldwide​

ISO 13485:2016​
Quality management specific to medical devices​

ISO 9001:2015​
Quality management system for all processes​

Team

Warning

Access Restricted to Healthcare Professionals

The promotional information regarding medical devices, in vitro diagnostic medical devices, and surgical medical supplies contained in this section is intended exclusively for healthcare professionals. Public access to promotional content is not permitted; any advertising messages are disseminated in compliance with the New Guidelines of the Italian Ministry of Health on Healthcare Advertising (published on July 21, 2025). By proceeding, you declare that you are a healthcare professional.